A blood test may rapidly distinguish brain bleeds from clot-caused strokes, even before people with stroke symptoms reach the ...

DIABETES, Parkinson's disease, degenerative disc disease, macular degeneration, stroke — what do these have in common?

The work could lead to improvements to stem cell therapy and contribute to the development of other treatments with similar impacts on the brain. An ischemic stroke occurs when blood flow to part ...

A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant ... that would stave off cancer. “A therapy could target the inflammasome, but ...

Some people might have stem cells from donated umbilical cord blood. But this is not as commonly used. The central line can stay in your vein for many months. So you don't need to have needles in your ...

SINGAPORE: Cordlife announced its cord blood banking service and human tissue banking service ... non-viable and unlikely to be suitable for stem cell transplants. Shares in Cordlife jumped ...

Stroke remains a leading global cause of morbidity and mortality. While thrombolysis and thrombectomy are effective in restoring blood flow ... the role of cell delivery in stroke therapy, as well as ...

Bayer’s Parkinson’s disease cell therapy is moving into late-stage testing, with the upcoming trial set to be the first registrational phase 3 study for an investigational allogeneic cell ...

Renal fibrosis is one of the main pathological features of chronic kidney disease (CKD), and its treatment has been a hot research topic. Recent studies have shown that stem cell therapy can ... of ...

The therapeutic candidate (Regenecyte) is under development for the treatment ... stroke, cerebral palsy and post-COVID syndrome, long crown syndrome. The therapeutic candidate comprises of allogeneic ...